Resources

Complementing Tissue Testing with Plasma mutation Profiling Improves Therapeutic Decision Making for Lung Cancer Patients

• Journal Title: medRxiv
• Author: Yukti Choudhury, Min-Han Tan, Jun Li Shi, Augustine Tee, Kao Chin Ngeow, Jonathan Poh, Ruth Rosalyn Goh, Jamie Mong

Analytical and Clinical Validation of an Amplicon-based Next Generation Sequencing Assay for Ultrasensitive Detection of Circulating Tumor DNA

• Journal Title: medRxiv
• Author: Jonathan Poh, Kao Chin Ngeow, Michelle Pek, Kian-Hin Tan, Jing Shan Lim, Hao Chen, Choon Kiat Ong, Jing Quan Lim, Soon Thye Lim, Chwee Ming Lim, Boon Cher Goh, Yukti Choudhury

Lucence Presents New Data on Liquid Biopsy for Late-stage Cancer Monitoring, Treatment Guidance

• Journal Title: GenomeWeb
• Author: John Gilmore

AmpliMark™ Technical Sheet

LiquidHALLMARK® Provider’s Brochure

Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.

• Journal Title: ASCO
• Author: Wei Wu, Jing Shan Lim, Jonathan Poh, Trever G. Bivona